HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terence Davis Selected Research

SB 203580

1/2016The effect of RO3201195 and a pyrazolyl ketone P38 MAPK inhibitor library on the proliferation of Werner syndrome cells.
1/2013The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome.
12/2011Investigating the role of c-Jun N-terminal kinases in the proliferation of Werner syndrome fibroblasts using diaminopyridine inhibitors.
6/2010Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.
6/2010Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblasts.
4/2007The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature aging.
5/2006Prevention of accelerated cell aging in the Werner syndrome.
11/2005Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Terence Davis Research Topics

Disease

19Werner Syndrome (Werner's Syndrome)
04/2016 - 04/2003
3Neoplasms (Cancer)
06/2018 - 01/2005
3Genomic Instability
02/2013 - 04/2007
1Nijmegen Breakage Syndrome
02/2015
1Rothmund-Thomson Syndrome (Syndrome, Rothmund-Thomson)
10/2013
1Progeria (Hutchinson Gilford Syndrome)
02/2013
1Ataxia Telangiectasia (Louis Bar Syndrome)
06/2009
1Premature Aging
11/2005

Drug/Important Bio-Agent (IBA)

13p38 Mitogen-Activated Protein KinasesIBA
04/2016 - 11/2005
8SB 203580IBA
01/2016 - 11/2005
5Phosphotransferases (Kinase)IBA
12/2011 - 04/2007
45- amino- 1- (4- fluorophenyl)- 4- (3- (2,3- dihydroxypropoxy)benzoyl)pyrazoleIBA
01/2016 - 07/2008
3KetonesIBA
01/2016 - 07/2008
3VX-745IBA
09/2010 - 11/2009
3Telomerase (Telomerase Reverse Transcriptase)IBA
12/2005 - 04/2003
2Pharmaceutical PreparationsIBA
06/2018 - 11/2005
2Proteins (Proteins, Gene)FDA Link
06/2018 - 02/2015
2MAP-kinase-activated kinase 2IBA
06/2015 - 01/2013
2doramapimodIBA
06/2010 - 11/2006
13-pyridinylboronic acidIBA
06/2015
12-chloroquinolineIBA
06/2015
1AcidsIBA
06/2015
1BromidesIBA
06/2015
1GalactosidasesIBA
02/2015
1Actins (F Actin)IBA
02/2015
1A-Form DNA (A-DNA)IBA
02/2013
1Adenosine Triphosphate (ATP)IBA
09/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2010
1Biological ProductsIBA
06/2010
1Therapeutic UsesIBA
02/2010
1VX (EDIM)IBA
09/2007
1pyrazoleIBA
11/2006
1CarbamatesIBA
11/2006
1Mitogen-Activated Protein Kinase 14IBA
11/2006
1Urea (Carbamide)FDA LinkGeneric
11/2006
1CytokinesIBA
11/2005
1DNA (Deoxyribonucleic Acid)IBA
04/2003

Therapy/Procedure

2Therapeutics
06/2018 - 12/2011
1Radiotherapy
06/2018
1Drug Therapy (Chemotherapy)
06/2018